Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03080818
Other study ID # Kent State University
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2017
Est. completion date July 1, 2019

Study information

Verified date February 2020
Source Kent State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will determine whether supplementation of probiotic Lactobacillus Rhamnosus GG improves psychological status in middle age and older adults through a 12-week, randomized, double-blind, placebo-controlled clinical trial. Secondary analyses will be conducted to examine the possible benefits of probiotic supplementation on cognitive function and markers of physical health.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date July 1, 2019
Est. primary completion date January 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 55 Years to 75 Years
Eligibility Inclusion Criteria:

- Age 55-75 years

- Able to speak and read English

Exclusion Criteria:

- History of neurological, developmental, or severe psychiatric disorder (e.g. dementia, stroke, schizophrenia);

- Antibiotic use in the past 30 days;

- History of significant stomach or GI surgery (e.g. gastric bypass, cholecystectomy);

- History of alcohol or illicit drug dependence;

- History of severe heart, kidney, or liver problems (e.g. heart failure, liver failure);

- Regular use of an acid-blocking medication in the past 30 days (i.e. proton pump inhibitor, H2 blocker);

- Likely immunosuppression (e.g. chemotherapy treatment);

- Regular use of other pre- or probiotic supplements in the past 30 days;

- Severe gastrointestinal conditions including celiac disease, Crohn's disease, or diverticulitis.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Probiotic - Lactobacillus Rhamnosus GG
2 capsules per day for 90 days
Other:
Placebo
2 placebo capsules per day for 90 days

Locations

Country Name City State
United States Kent State Uniersity Kent Ohio

Sponsors (2)

Lead Sponsor Collaborator
Kent State University iHealth

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in score on Center for Epidemiologic Studies Depression - R (CES-D-R) Depressive symptoms Baseline and 12 week follow up
Primary Change in score on State-Trait Anxiety Inventory Anxiety symptoms Baseline and 12 week follow up
Primary Change in score on Perceived Stress Scale Subjective stress Baseline and 12 week follow up
Primary Change in score on Positive and Negative Affect Schedule Fluctuations in affect Baseline and 12 week follow up
Primary Change in score on Profile of Mood States Fluctuations in affect - acute Baseline and 12 week follow up
Primary Change in score on Warwick-Edinburgh Mental Well-Being Scale Subjective wellbeing Baseline and 12 week follow up
Primary Change in score on OECD Life Satisfaction scale (short) Subjective wellbeing - general Baseline and 12 week follow up
Primary Change in score on Response to Stressful Events Scale Emotion regulation Baseline and 12 week follow up
Primary Change in score on Connor-Davidson Resilience Scale Emotional resilience Baseline and 12 week follow up
Secondary Change in Picture Sequence Memory Test and Auditory Verbal Learning Test scores Memory Baseline and 12 week follow up
Secondary Change in Dimension Card Sort Test, Flanker Inhibitory Control, and List Sorting Working Memory Test scores Executive function/Attention Baseline and 12 week follow up
Secondary Change in Pattern Comparison Processing Speed Test scores Processing Speed Baseline and 12 week follow up
Secondary Change in SF-36 scores Quality of Life Baseline and 12 week follow up
Secondary Change in Pittsburgh Sleep Quality Index scores Sleep patterns Baseline and 12 week follow up
Secondary Change in Gastrointestinal Symptom Rating Scale scores Subjective gastrointestinal symptoms Baseline and 12 week follow up
Secondary Change in HbA1c and fasting glucose values Laboratory measures of glycemic control Baseline and 12 week follow up
Secondary Change in C-reactive protein, Interleukin-6, and TNF-alpha values Laboratory measures of inflammation Baseline and 12 week follow up
Secondary Change in Total Cholesterol, HDL, LDL, and VLDL values Laboratory meausres of lipid levels Baseline and 12 week follow up
Secondary Change in waking cortisol levels Laboratory measure of cortisol Baseline and 12 week follow up
Secondary Change in composition of the gut microbiome Laboratory measure of gut microbiome Baseline and 12 week follow up
Secondary Change in oral microbiome composition Laboratory measure of oral microbiome Baseline and 12 week follow up
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A